1. Home
  2. ZLAB vs BBAR Comparison

ZLAB vs BBAR Comparison

Compare ZLAB & BBAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • BBAR
  • Stock Information
  • Founded
  • ZLAB 2013
  • BBAR 1886
  • Country
  • ZLAB China
  • BBAR Argentina
  • Employees
  • ZLAB N/A
  • BBAR N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • BBAR Commercial Banks
  • Sector
  • ZLAB Health Care
  • BBAR Finance
  • Exchange
  • ZLAB Nasdaq
  • BBAR Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • BBAR 3.4B
  • IPO Year
  • ZLAB 2017
  • BBAR N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • BBAR $14.65
  • Analyst Decision
  • ZLAB Buy
  • BBAR Buy
  • Analyst Count
  • ZLAB 5
  • BBAR 1
  • Target Price
  • ZLAB $54.28
  • BBAR $27.00
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • BBAR 645.0K
  • Earning Date
  • ZLAB 08-05-2025
  • BBAR 08-20-2025
  • Dividend Yield
  • ZLAB N/A
  • BBAR 6.67%
  • EPS Growth
  • ZLAB N/A
  • BBAR 9.91
  • EPS
  • ZLAB N/A
  • BBAR 0.57
  • Revenue
  • ZLAB $418,326,000.00
  • BBAR $2,595,064,489.00
  • Revenue This Year
  • ZLAB $44.07
  • BBAR N/A
  • Revenue Next Year
  • ZLAB $49.13
  • BBAR $35.30
  • P/E Ratio
  • ZLAB N/A
  • BBAR $9.00
  • Revenue Growth
  • ZLAB 43.72
  • BBAR N/A
  • 52 Week Low
  • ZLAB $16.01
  • BBAR $7.05
  • 52 Week High
  • ZLAB $44.34
  • BBAR $25.01
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • BBAR 31.25
  • Support Level
  • ZLAB $34.26
  • BBAR $15.35
  • Resistance Level
  • ZLAB $35.72
  • BBAR $16.59
  • Average True Range (ATR)
  • ZLAB 1.12
  • BBAR 0.74
  • MACD
  • ZLAB -0.54
  • BBAR -0.06
  • Stochastic Oscillator
  • ZLAB 3.83
  • BBAR 0.00

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

Share on Social Networks: